非小細胞肺がん
レジメン名をクリックするとレジメンの投与スケジュールが閲覧できます。
最終更新日:2024年7月24日
- NSC-101:CBDCA+weekly PTX
- NSC-103:CBDCA+PTX
- NSC-104:DOC単剤
- NSC-105:VNR
- NSC-106:VNR+GEM
- NSC-110:CDDP+GEM
- NSC-112:GEM単剤
- NSC-113:CDDP+VNR
- NSC-115:CDDP+DOC
- NSC-116:CBDCA+GEM
- NSC-122:CDDP+S-1
- NSC-124:CDDP+DOC concurrent TRT
- NSC-126:PEM単剤
- NSC-127:CBDCA+PEM
- NSC-129:CBDCA/PTX+Bv
- NSC-130:CBDCA/PEM+Bv
- NSC-131:CBDCA+S-1
- NSC-132:Bv+Erlotinib
- NSC-136:CDDP+PEM
- NSC-137:wCBDCA+wPTX concurrent RT
- NSC-138:weely CDDP+CPT-11
- NSC-140:CBDCA+wPTX+Bv
- NSC-141:CBDCA+nab-PTX
- NSC-156:Nivolumb単剤
- NSC-162:RAM+DOC
- NSC-163:Pembrolizumab単剤
- NSC-167:高齢者CBDCA単剤(放射線化学療法)
- NSC-169:CDDP/PEM+Bv
- NSC-171:Atezolizumab単剤
- NSC-173:Durvalumab単剤
- NSC-174:Pembrolizumab+CDDP/PEM
- NSC-175:Pembrolizumab+CBDCA/PEM
- NSC-176:Pembrolizumab+CBDCA/PTX
- NSC-177:Pembrolizumab+CBDCA/nab-PTX
- NSC-178:Atezolizumab+CBDCA/PTX+Bv
- NSC-182:Atezolizumab+CBDCA/nab-PTX
- NSC-183:Necitumumab+CDDP/GEM
- NSC-187:Atezolizumab+CBDCA+PEM(75歳以上)
- NSC-189:Atezolizumab+CBDCA+PEM
- NSC-190:Atezolizumab+CDDP+PEM
- NSC-192:Nivolumab+lpilimumab
- NSC-193:Nivolumab+lpilimumab+CDDP+PEM
- NSC-194:Nivolumab+lpilimumab+CBDCA+PEM
- NSC-195:Nivolumab+lpilimumab+CBDCA+PTX
- NSC-196:RAM+Erlotinib orGefitinib
- NSC-197:Bv+Erlotinib
- NSC-200:adj Atezolizumab単剤